Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Innovation and Product Development news
12 June 2026
Roche VENTANA PTEN (SP218) FDA-cleared as PTEN companion diagnostic in prostate cancer
First FDA-cleared IHC companion diagnostic to detect PTEN protein loss and select patients for capivasertib (TRUQAP) plus abiraterone therapy.
12 June 2026
Merck: FDA approves KEYTRUDA and KEYTRUDA QLEX with WELIREG for adjuvant ccRCC
FDA cleared PD‑1 plus HIF‑2α adjuvant regimens after Phase 3 showed 28% lower recurrence risk and 81% vs 74% 24‑month DFS; notable anemia, hypoxia and treatment discontinuations.
12 June 2026
BASF’s Tinosorb S (bemotrizinol) approved by FDA as first new U.S. sunscreen active in 27 years
FDA clears bemotrizinol, a broad‑spectrum, photostable UV filter that enables longer‑lasting, stronger UVA/UVB protection and improved formulation stability.
12 June 2026
Chugai files Tecentriq for maintenance therapy after definitive chemoradiotherapy in locally advanced esophageal cancer
Submission seeks approval of an anti‑PD‑L1 agent as maintenance therapy after definitive chemoradiotherapy, supported by SKYSCRAPER‑07 Phase III interim results.
12 June 2026
GSK’s momelotinib gains orphan drug status in US and EU for VEXAS
Orphan designations back development of momelotinib for VEXAS; ATLAS phase II/III underway with design to be shown at EHA 2026.
11 June 2026
Genmab: Epcoritamab plus R2 shows consistent benefit across EPCORE FL‑1 subgroups
Post‑hoc subgroup analysis of the Phase 3 EPCORE FL‑1 shows epcoritamab+rituximab+lenalidomide delivers consistent PFS, ORR and CRR gains with a manageable safety profile across risk and fitness subgroups.
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
11 June 2026
Novo Nordisk: Wegovy pill approved in UK as first daily GLP-1 weight-loss tablet in Europe
Daily 25 mg semaglutide tablet approved as adjunct to diet and exercise for adults with obesity or overweight plus a weight‑related condition; private prescriptions expected soon.
11 June 2026
Johnson & Johnson’s IMAAVY shows rapid, durable hemoglobin gains in Phase 2/3 wAIHA trial
Nipocalimab 30 mg/kg produced rapid hemoglobin rises and ~3× more durable responders versus placebo at 24 weeks, with early fatigue improvement and reduced steroid use.
11 June 2026
Takeda's zasocitinib outperforms deucravacitinib in Phase 3 psoriasis head-to-head
Once-daily oral TYK2 inhibitor showed statistical superiority to deucravacitinib for PASI100 and key secondary endpoints, with >35% achieving complete skin clearance at week 16.
11 June 2026
Evonik launches low‑carbon peracetic acid for Europe
Peracetic acid produced using bio-based acetic acid and low‑carbon hydrogen peroxide; mass‑balance accounting lets customers lower Scope 3 emissions transparently.
10 June 2026
Genentech: FDA grants Priority Review for Tecentriq plus chemotherapy in stage III dMMR/MSI‑H colon cancer
FDA accepted an sBLA for adjuvant PD‑L1 therapy plus chemotherapy in stage III dMMR/MSI‑H colon cancer; agency decision expected Oct 9, 2026.
10 June 2026
Aptar N‑Sorb patent allowed by USPTO for packaging-based nitrosamine mitigation
USPTO allowed a patent for N‑Sorb, a packaging material that reduces nitrosamines across multiple APIs and may support FDA Orange Book strategies.
10 June 2026
dsm-firmenich: FDA approves bemotrizinol (PARSOL® Shield) for U.S. suncare
FDA clears bemotrizinol (PARSOL® Shield), the first new U.S. sunscreen active in 25+ years, enabling broad‑spectrum, photostable formulas with low‑concentration efficacy.
10 June 2026
Evonik opens pilot plant for high-performance AEM membrane
Pilot-scale polymer membrane production for AEM electrolysis targets up to 2.5 GW/year, enabling lower-cost green hydrogen and manufactured without PFAS.
10 June 2026
Evonik advances chemical recycling with Purocel adsorbents and modular units
Improves pyrolysis-oil quality for steam crackers by removing chlorine, nitrogen and silicon; specific adsorbents cut chlorides up to threefold and modular columns enable flexible plant integration.
10 June 2026
H-Power signs deal to sell 5,000 kg green hydrogen from cracked ammonia to Protium
First UK commercial bulk sale of hydrogen from cracked ammonia; 5,000 kg of ISO 14687 Grade D (99.97%) green hydrogen; permit amended to allow third‑party sales.
10 June 2026
H-Power sells two LC30 fuel cell generators to TAMGO for Saudi trials
Two LC30 units will run hot-weather field trials in Saudi Arabia, then customer trials and GCC demonstrations; TAMGO will act as exclusive regional distributor.
10 June 2026
Evonik’s Ecobiol PRO: faster-germinating probiotic to reduce antibiotics in poultry
Faster-germinating poultry probiotic reduces intestinal damage and raises survival against Clostridium perfringens, offering an alternative to routine antibiotics.
10 June 2026
ARLANXEO and Covestro reduce Baypren GWP using ISCC PLUS chlorine
Switch to ISCC PLUS-certified chlorine lowers chloroprene rubber emissions; full conversion completed Jan 2026, ~20% GWP cut versus 2025; Eco grades add certified butadiene.
10 June 2026
Evonik launches Innovation Factory to accelerate market-ready innovations
New unit targets faster, market-driven development and resilience; aims up to €300m contribution by 2032 and shifts researchers into business lines.
10 June 2026
Topsoe wins DKK 25m for PowerFactor to standardize Power‑to‑X grid integration
Grant-backed project will replace case-by-case grid studies with standardized methods, using electrolyzers, eREACT, SOEC and grid emulation at a Viborg pilot site.
10 June 2026
Air Liquide launches Cryocap FG pilot for cement CO₂ capture
3,000 Nm³/h Cryocap FG pilot at Holcim’s CaptureLab pre-treats and preconcentrates cement flue gas for CO₂ purification; modular and relocatable.
10 June 2026
Holcim launches CaptureLab carbon capture test platform
Industrial-scale, plug-and-play test platform in France for validating diverse carbon-capture technologies on real cement emissions.
9 June 2026
Moeve 2025 Environmental Statement for La Rábida and Palos
Annual report shows €33.8m+ invested in environmental upgrades, 100% renewable power in 2025, major waste recovery and water-use cuts, plus EU funding for green hydrogen project.
9 June 2026
Lilly gains FDA approval for EBGLYSS every‑eight‑week maintenance dosing
New every‑eight‑week maintenance option offers as few as six injections per year and can be used without mandatory topical therapy from treatment start.
9 June 2026
Takeda: FDA accepts sBLA for IV ENTYVIO in pediatric UC and Crohn’s
FDA accepted an sBLA to extend IV vedolizumab (ENTYVIO) to children aged 2+ with moderately to severely active UC and Crohn’s; PDUFA Q1 2027.
9 June 2026
Honeywell launches Experion Cognition for autonomous control rooms at Borouge Ruwais
AI-enabled control system makes predictive recommendations and automated decisions to reduce anomalies, increase production and compensate for operator skill gaps; commercial from Q3 2026.
9 June 2026
ProLogium and OPmobility to co-develop solid‑state EV battery modules
Testing of solid‑state cells, module design and aligned test protocols to translate 900 Wh/L cell metrics into OEM‑ready EV modules.
9 June 2026
European Commission launches €1.5bn Battery Booster Facility
Mobilises up to €1.5bn from ETS revenues as interest‑free loans to scale EV battery cell production in the EEA; call opens Q3 2026.
9 June 2026
PureCycle & Innovia Films produce white, cavitated BOPP using PureFive Choice™ recycled PP
White, cavitated BOPP film made with >40% post‑consumer recycled polypropylene showed virgin‑like processing and comparable mechanical, barrier and sealing performance.
Next →
